A New Orthotopic Model of Human Breast Cancer in Immunocompetent Rats

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3761-3766

  Akla, Barbara ^a   Monteil, Jacques ^b   Paraf, Francois ^b   Sturtz, Franck ^a,b   Rigaud, Michel ^a,b  

^a UNIVERSITY OF LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Breast cancer; Cyclosporin A; FDG; MDA MB 231 cells; MIBI; Orthotopic model; Rat

Indexed keywords

CYCLOSPORIN A; ESTROGEN; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER EPIDEMIOLOGY; CANCER GRAFT; CELL INFILTRATION; CELL SUSPENSION; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; IMAGING SYSTEM; IMMUNOCOMPETENT CELL; INJECTION; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SCINTIGRAPHY; TISSUE SECTION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE AGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; MIDDLE AGED; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM TC 99M SESTAMIBI; TRANSPLANTATION, HETEROLOGOUS;

EID: 0344010987     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fidler IJ: Critical factors in the biology of human cancer metastasis: twentyeighth G.H.A. Clowes memorial award lecture. Cancer Res 50: 6130-8, 1990.
2. Cardiff RD and Munn RJ: Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett 90: 13-9, 1995.
3. Cardiff RD and Wellings SR: The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4: 105-22, 1999.
4. Gould MN: Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol 6: 147-52, 1995.
5. Hutchinson JN and Muller WJ: Transgenic mouse models of human breast cancer. Oncogene 19: 6130-7, 2000.
6. Jordan VC, Gottardis MM, Robinson SP and Friedl A: Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer. J Steroid Biochem 34: 169-76, 1989.
7. Spang-Thomsen M, Rygaard K, Hansen L, Halvorsen AC, Vindelov LL and Brunner N: Growth kinetics of four human breast carcinomas grown in nude mice. Breast Cancer Res Treat 14: 235-43, 1989.
8. Fidler IJ, Yano S, Zhang RD, Fujimaki T and Bucana CD: The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3: 53-7, 2002.
9. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J and Anderson RL: A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 17: 163-70, 1999.
10. Miller FR and McInerney D: Epithelial component of hosttumor interactions in the orthotopic site preference of a mouse mammary tumor. Cancer Res 48: 3698-701, 1988.
11. Miller FR: Comparison of metastasis of mammary tumors growing in the mammary fatpad versus the subcutis. Invasion Metastasis 1: 220-6, 1981.
12. Miller FR, Medina D and Heppner GH: Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res 41: 3863-7, 1981.
13. Monsky WL, Mouta Carreira C, Tsuzuki Y, Gohongi T, Fukumura D and Jain RK: Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 8: 1008-13, 2002.
14. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863-71, 1988.
15. Steel GG and Peckham MJ: Human tumour xenografts: a critical appraisal. Br J Cancer Suppl 41: 133-41, 1980.
16. Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C and Sun L: A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Res 59: 5041-6, 1999.
17. El Abdaimi K, Dion N, Papavasiliou V, Cardinal PE, Binderup L, Goltzman D, Ste-Marie LG and Kremer R: The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 60: 4412-8, 2000.
18. Hardman WE, Avula CP, Fernandes G and Cameron IL: Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 7: 2041-9, 2001.
19. Hiraga T, Williams PJ, Mundy GR and Yoneda T: The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 61: 4418-24, 2001.
20. Cailleau R, Young R, Olive M and Reeves WJ Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-74, 1974.
21. Klement G, Huang P, Mayer B, Green SK, Man S, Bohlen P, Hicklin D and Kerbel RS: Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts. Clin Cancer Res 8: 221-32, 2002.
22. Carlsson G, Gullberg B and Hafstrom L: Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 105: 20-3, 1983.
23. Steel GG, Courtenay VD and Rostom AY: Improved immunesuppression techniques for the xenografting of human tumours. Br J Cancer 37: 224-30, 1978.
24. Hoogenhout J, Kazem I, Jerusalem CR, Bakkeren JA, de Jong J, Kal HB and van Munster PJ: Growth pattern of tumor xenografts in Wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin A. Int J Radiat Oncol Biol Phys 9: 871-9, 1983.
25. Goodman MM, McCullough JL, Biren CA and Barr RJ: A model of human melanoma in cyclosporine-immunosuppressed rats. J Invest Dermatol 88: 141-4, 1987.
26. Price JE: Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39: 93-102, 1996.
27. Price JE, Polyzos A, Zhang RD and Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-21, 1990.
28. Price JE and Zhang RD: Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 8: 285-97, 1990.
29. Meschter CL, Connolly JM and Rose DP: Influence of regional location of the inoculation site and dietary fat on the pathology of MDA-MB-435 human breast cancer cell-derived tumors grown in nude mice. Clin Exp Metastasis 10: 167-73, 1992.
30. Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, Oster ZH, Sacker DF, Shiue CY, Turner H, Wan CN, Wolf AP and Zabinski SV: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21: 670-5, 1980.
31. Chatziioannou AF, Cherry SR, Shao Y, Silverman RW, Meadors K, Farquhar TH, Pedarsani M and Phelps ME: Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med 40: 1164-75, 1999.
32. Prats E, Aisa F, Abos MD, Villavieja L, Garcia-Lopez F, Asenjo MJ, Razola P and Banzo J: Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 40: 296-301, 1999.
33. Ohira H, Kubota K, Ohuchi N, Harada Y, Fukuda H and Satomi S: Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models. J Nucl Med 41: 1561-8, 2000.
34. Oriuchi N, Jibu T, Milas L, Choe J, Kuang L, Kim EE, Hunter NR, Wallace S and Podoloff DA: Assessment of resistance to paclitaxel of murine tumors by (99m)Tc-MIBI/(201)TI dualradionuclide imaging. Nucl Med Biol 27: 127-33, 2000.
35. Kao CH, Shiau YC, Shen YY and Yen RF: Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 94: 1981-6, 2002.
36. Fuster D, Munoz M, Pavia J, Palacin A, Bellet N, Mateos JJ, Martin F, Ortega M, Setoain FJ and Pons F: Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake. Nucl Med Commun 23: 31-8, 2002.
37. Kao CH, Tsai SC, Liu TJ, Ho YJ, Wang JJ, Ho ST and ChangLai SP: P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res 61: 1412-4, 2001.
38. Bergmann R, Brust P, Scheunemann M, Pietzsch HJ, Seifert S, Roux F and Johannsen B: Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein. Nucl Med Biol 27: 135-41, 2000.
39. Liang JA, Shiau YC, Yang SN, Lin FJ, Kao A and Lee CC: Prediction of chemotherapy response in untreated malignant lymphomas using technetium-99m methoxyisobutylisonitrile scan: comparison with P-glycoprotein expression and other prognostic factors. A preliminary peport. Jpn J Clin Oncol 32: 140-5, 2002.